Skip to main content

Table 2 Patients' clinical and analytical data by baseline group (BP: Blood pressure, Heart Rate (bpm); BMI Body Mass Index, Adominal circumference (cm); AST: Aspartate Aminotransferase; ALT: alanine aminotransferase; GGT: Gamma Glutamyl Transpeptidase CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration)

From: Effectiveness of motivational interviewing in patients with dyslipidemia: a randomized cluster trial

VARIABLES Experimental group n = 107 Control group n = 120 P value
Systolic BP (mmHg): Mean ± SD 129.26 ± 14.54 130.17 ± 15.67 0.595
Diastolic BP (mmHg): Mean ± SD 79.04 ± 9.11 77.90 ± 9.49 0.228
Heart rate (bpm) (mmHg): Mean ± SD 74.08 ± 10.06 74.18 ± 9.59 0.927
BMI: Mean ± SD 28.47 ± 3.90 28.41 ± 4.47 0.670
Waist Circumference (cm): Mean ± SD 94.47 ± 12.00 95.15 ± 11.51 0.744
Family history of early CVD: n (%) 24 (22.4) 16 (13.3) 0.073
ECG: n (%)    0.466
 Normal 95 (88.8) 105 (87.5)
 Alterations 7 (6.5) 5 (4.2)
 Unknown 5 (4.7) 10 (8.3)
ANALYTICAL DATA: Mean ± SD  
 Total Cholesterol (mg/dl) 263.44 ± 28.26 259.26 ± 26.09 0.098
 LDL Cholesterol (mg/dl) 171.89 ± 27.28 171.10 ± 28.56 0.734
 HDL Cholesterol (mg/dl) 57.03 ± 17.63 55.55 ± 14.53 0.508
 Triglycerides (mg/dl) 170.64 ± 87.93 170.30 ± 106.05 0.516
 Creatinine (mg/dl) 0.83 ± 0.17 0.79 ± 0.19 0.039
 Glucose (mg/dl) 95.65 ± 10.68 95.76 ± 17.19 0.463
 Uric Acid (mg/dl) 4.86 ± 1.52 4.90 ± 1.56 0.883
 GOT (UI/l) 22.60 ± 7.96 24.26 ± 11.67 0.658
 GPT (UI/l) 25.65 ± 12.0 26.29 ± 16.90 0.693
 GGT (UI/l) 38.16 ± 35.47 36.14 ± 29.71 0.966
 CKD-EPI (ml/min/1.73 m2) 91.06 ± 12.92 92.98 ± 15.06 0.135
VASCULAR RISK: Mean ± SD    
 SCORE (%) 1.32 ± 1.50 1.54 ± 1.72 0.346
 REGICOR (%) 4.48 ± 2.61 4.47 ± 2.50 0.693
 FRAMINGHAM (%) 9.52 ± 6.05 9.98 ± 6.37 0.447